Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 1/20 | 0.59 |
| ▸ | CASP7 | P55210 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | HSD17B1 | P14061 | 3/20 | 0.54 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.53 |
| ▸ | GRM5 | P41594 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 4/20 | 0.46 |
| ▸ | MAOA | P21397 | 3/20 | 0.46 |
| ▸ | PRKCI | P41743 | 1/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.45 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29726050 | 1.00 | CASP1 (0.59) | CASP1CASP7HSD17B10HSD17B1SRD5A1 | |
| SCHEMBL315877 | 0.88 | MAOA (0.61) | CASP1CASP7HSD17B10HSD17B1SRD5A1 | |
| SCHEMBL2585151 | 0.88 | MAOA (0.59) | CASP1CASP7HSD17B10HSD17B1SRD5A1 | |
| SCHEMBL3372953 | 0.84 | SRD5A1 (0.54) | SRD5A1CYP11B1CYP11B2CYP19A1 | |
| SCHEMBL1745120 | 0.84 | HSD17B1 (0.69) | CASP1CASP7HSD17B10HSD17B1GRM5 | |
| SCHEMBL1150109 | 0.83 | PBRM1 (0.59) | CASP1CASP7HSD17B10HSD17B1SRD5A1 | |
| SCHEMBL29443089 | 0.83 | PBRM1 (0.59) | CASP1CASP7HSD17B10HSD17B1SRD5A1 | |
| SCHEMBL8598463 | 0.82 | CA1 (0.47) | CASP1CASP7HSD17B10HSD17B1SRD5A1 | |
| SCHEMBL9791679 | 0.78 | NOTUM (0.51) | CASP1CASP7HSD17B10HSD17B1SRD5A1 | |
| SCHEMBL8251126 | 0.78 | MAPK14 (0.55) | SRD5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 946 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113861113-B | Preparation and application of fused ring pyridine compound and derivative thereof | 中国科学院福建物质结构研究所 | 2022-12-06 | — | — | CN | claimed |
| CN-113861113-A | Preparation and application of fused ring pyridine compound and derivative thereof | 中国科学院福建物质结构研究所 | 2021-12-31 | — | — | CN | claimed |
| CN-111253260-A | Synthesis method of β -tertiary alcohol ester compound | 赣南医学院 | 2020-06-09 | — | — | CN | claimed |
| EP-2459540-A2 | PREPARATION OF FIPAMEZOLE | Dr. Reddy's Laboratories, Ltd. (IN) | 2012-06-06 | — | — | EP | claimed |
| US-20120130084-A1 | PREPARATION OF FIPAMEZOLE | DR. REDDY'S LABORATORIES, INC. (US) | 2012-05-24 | — | — | US | claimed |
| WO-2011014613-A2 | PREPARATION OF FIPAMEZOLE | DR. REDDY'S LABORATORIES LTD. (IN) | 2011-02-03 | — | — | WO | claimed |
| US-20090197167-A1 | Fluorinated Additives For Lithium Ion Batteries | SOLVAY FLUOR GMBH (DE) | 2009-08-06 | — | — | US | claimed |
| EP-1938404-A1 | FLUORINATED ADDITIVES FOR LITHIUM ION BATTERIES | Solvay Fluor GmbH (DE) | 2008-07-02 | — | — | EP | claimed |
| WO-2007042471-A1 | FLUORINATED ADDITIVES FOR LITHIUM ION BATTERIES | SOLVAY FLUOR GMBH (DE) | 2007-04-19 | — | — | WO | claimed |
| US-12630516-B2 | Compounds | NRG THERAPEUTICS LTD. (GB) | 2026-05-19 | — | — | US | disclosed |
| US-20260124204-A1 | METALLOENZYME INHIBITOR COMPOUNDS | EIKONIZO THERAPEUTICS, INC. (US) | 2026-05-07 | — | — | US | disclosed |
| EP-4735449-A1 | TETRACYCLIC COMPOUNDS CONTAINING A FUSED INDOLE FOR TREATING APOL1-MEDIATED CHRONIC KIDNEY DISEASE | OmniAB, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-3964518-B1 | CD73 INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | ABBISKO THERAPEUTICS CO LTD (CN) | 2026-01-28 | — | — | EP | disclosed |
| US-20260001846-A1 | SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS | SERVIER LAB (FR) | 2026-01-01 | — | — | US | disclosed |
| EP-0247724-A1 | Thiadiazinon derivatives | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1987-12-02 | — | — | EP | disclosed |
| EP-0199845-A1 | Imidazolylalkylguanidin derivatives, process for their preparation and pharmaceutical compositions containing them | HEUMANN PHARMA GMBH & CO (DE) | 1986-11-05 | — | — | EP | disclosed |
| US-4537892-A | ANTIDIABETIC AGENTS | ALCON LABORATORIES, INC. (US) | 1985-08-27 | — | — | US | disclosed |
| EP-0137333-A2 | Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase | ALCON LABORATORIES, INC. (US) | 1985-04-17 | — | — | EP | disclosed |
| EP-0009554-B1 | INDANYL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | SCHERING AKTIENGESELLSCHAFT (DE) | 1983-04-27 | — | — | EP | disclosed |
| US-4244960-A | HERBICIDES OR ANTIINFLAMMATORY AGENTS | SCHERING, AKTIENGESELLSCHAFT (DE) | 1981-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630516-B2 | Compounds | CYP4B1, CYP1B1, NR4A1 | CASP1 2108/4885CASP7 1745/4885HSD17B10 169/4885 |
| US-20260001846-A1 | SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS | BCL2, BCL2A1, BAX | CASP1 21/4885CASP7 17/4885HSD17B10 571/4885 |
| US-20120130084-A1 | PREPARATION OF FIPAMEZOLE | FIP1L1, CYP3A7, CYP3A4 | CASP1 2835/4885CASP7 850/4885HSD17B10 1282/4885 |
| US-20260124204-A1 | METALLOENZYME INHIBITOR COMPOUNDS | HDAC6, HDAC3, HDAC1 | CASP1 4174/4885CASP7 3265/4885HSD17B10 211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.